Cash and Cash Equivalents, at Carrying Value in USD of Medtronic plc from Q1 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Medtronic plc quarterly Cash and Cash Equivalents, at Carrying Value history and change rate from Q1 2012 to Q3 2025.
  • Medtronic plc Cash and Cash Equivalents, at Carrying Value for the quarter ending 24 Oct 2025 was $1.28B, a 8.03% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Medtronic plc Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.28B -$112M -8.03% 24 Oct 2025 10-Q 25 Nov 2025
Q2 2025 $1.27B -$38M -2.9% 25 Jul 2025 10-Q 26 Aug 2025
Q1 2025 $2.22B +$934M +72.7% 25 Apr 2025 10-Q 25 Nov 2025
Q4 2024 $1.24B -$383M -23.6% 24 Jan 2025 10-Q 25 Feb 2025
Q3 2024 $1.39B +$83M +6.33% 25 Oct 2024 10-Q 26 Nov 2024
Q2 2024 $1.31B -$28M -2.09% 26 Jul 2024 10-Q 27 Aug 2024
Q1 2024 $1.28B -$259M -16.8% 26 Apr 2024 10-K 20 Jun 2025
Q4 2023 $1.62B -$2.9B -64.1% 26 Jan 2024 10-Q 27 Feb 2024
Q3 2023 $1.31B -$3.52B -72.8% 27 Oct 2023 10-Q 30 Nov 2023
Q2 2023 $1.34B -$801M -37.4% 28 Jul 2023 10-Q 31 Aug 2023
Q1 2023 $1.54B -$2.17B -58.5% 28 Apr 2023 10-K 20 Jun 2024
Q4 2022 $4.52B +$1.04B +30% 27 Jan 2023 10-Q 01 Mar 2023
Q3 2022 $4.83B +$1.93B +66.5% 28 Oct 2022 10-Q 01 Dec 2022
Q2 2022 $2.14B -$864M -28.8% 29 Jul 2022 10-Q 01 Sep 2022
Q1 2022 $3.71B +$121M +3.37% 29 Apr 2022 10-K 22 Jun 2023
Q4 2021 $3.48B -$1.6B -31.5% 28 Jan 2022 10-Q 03 Mar 2022
Q3 2021 $2.9B -$3.52B -54.8% 29 Oct 2021 10-Q 02 Dec 2021
Q2 2021 $3B -$3.5B -53.8% 30 Jul 2021 10-Q 02 Sep 2021
Q1 2021 $3.59B -$547M -13.2% 30 Apr 2021 10-K 23 Jun 2022
Q4 2020 $5.08B +$1.37B +36.9% 29 Jan 2021 10-Q 05 Mar 2021
Q3 2020 $6.42B +$2.46B +62% 30 Oct 2020 10-Q 03 Dec 2020
Q2 2020 $6.5B +$1.42B +27.9% 31 Jul 2020 10-Q 03 Sep 2020
Q1 2020 $4.14B -$253M -5.76% 24 Apr 2020 10-K 25 Jun 2021
Q4 2019 $3.71B +$6M +0.16% 24 Jan 2020 10-Q 28 Feb 2020
Q3 2019 $3.96B +$51M +1.3% 25 Oct 2019 10-Q 03 Dec 2019
Q2 2019 $5.08B +$700M +16% 26 Jul 2019 10-Q 30 Aug 2019
Q1 2019 $4.39B +$724M +19.7% 26 Apr 2019 10-K 19 Jun 2020
Q4 2018 $3.7B -$2.66B -41.8% 25 Jan 2019 10-Q 01 Mar 2019
Q3 2018 $3.91B -$1.62B -29.3% 26 Oct 2018 10-Q 29 Nov 2018
Q2 2018 $4.38B -$311M -6.63% 27 Jul 2018 10-Q 30 Aug 2019
Q1 2018 $3.67B -$1.3B -26.1% 27 Apr 2018 10-Q 30 Aug 2019
Q4 2017 $6.36B +$3.59B +130% 26 Jan 2018 10-Q 01 Mar 2019
Q3 2017 $5.53B +$2.58B +87.2% 27 Oct 2017 10-Q 29 Nov 2018
Q2 2017 $4.69B +$1.63B +53.3% 28 Jul 2017 10-Q 31 Aug 2018
Q1 2017 $4.97B +$2.09B +72.7% 28 Apr 2017 10-Q 01 Mar 2019
Q4 2016 $2.77B +$47M +1.73% 27 Jan 2017 10-Q 02 Mar 2018
Q3 2016 $2.95B +$576M +24.2% 28 Oct 2016 10-Q 04 Dec 2017
Q2 2016 $3.06B +$81M +2.72% 29 Jul 2016 10-Q 01 Sep 2017
Q1 2016 $2.88B -$1.97B -40.6% 29 Apr 2016 10-K 22 Jun 2018
Q4 2015 $2.72B -$14.5B -84.2% 29 Jan 2016 10-Q 03 Mar 2017
Q3 2015 $2.38B +$1.09B +84.8% 30 Oct 2015 10-Q 05 Dec 2016
Q2 2015 $2.98B +$2.98B 31 Jul 2015 10-Q 07 Sep 2016
Q1 2015 $4.84B +$3.44B +245% 24 Apr 2015 10-K 22 Jun 2018
Q4 2014 $17.2B 23 Jan 2015 10-Q 09 Mar 2016
Q3 2014 $1.29B 24 Oct 2014 10-Q 09 Dec 2015
Q2 2014 $0 12 Jun 2014 10-Q 27 Feb 2015
Q1 2014 $1.4B +$484M +52.7% 25 Apr 2014 10-K 27 Jun 2017
Q1 2013 $919M -$253M -21.6% 26 Apr 2013 10-K 28 Jun 2016
Q1 2012 $1.17B 27 Apr 2012 10-K 23 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.